BGV is a venture capital firm with a focus on early stage European biotech, medtech and diagnostics companies. The firm has a track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build teams. It prefers investing in areas where true scientific innovations, the unmet medical need and the potential to demonstrate a significant proof of concept all come together. It is based in Naarden, Netherlands and closely collaborates with Forbion Capital Partners.